Views & Analysis | Perspectives on pharma industry issues

R&D

Boosting biotech in Basel – with Valentina Francia

pharmaphorum speaks with Valentina Francia from Basel Area Business and Innovation about why many life sciences startups are finding success in Basel.

Sales & Marketing

Hiring of investor at meeting, men and women

Changing Faces: Agency, consultancy, and investor hires, Aug...

August and September brought leadership changes across healthcare communications, consulting, investment, and industry organisations.

R&D

clinical trial recruitment patient enrolment checklist

Why clinical trials lose a quarter of their patients before ...

Data fragmentation creates unnecessary burden on sponsors and the people clinical trials aim to serve.

R&D

Beyond recruitment: Creating patient engagement that lasts

In the fourth episode of the IQVIA-sponsored PSCS leadership video series, Zoltan Varga discusses the importance of understanding patient motivations

Patients

From bedside to breakthroughs: Reimagining the human experie...

Patients should be involved in the programme design process from the beginning, as co-creators with full influence over the outcome.

Views & Analysis

Tackling adherence is “only sustainable path to profit”

Every year, pharmaceutical companies lose an eye-watering $637bn through medication non-adherence – so why isn’t the industry taking this money-eating bull by the horns?

Views & Analysis

Changing hearts

Danish biotech Acesion Pharma is hoping to change the standard of care in atrial fibrillation.

Views & Analysis

The happiness factor

As part of pharmaphorum’s Eye on Innovation series, Richard Staines spoke to John Zibert, chief medical officer at LEO Pharma’s Innovation lab, about how the company wants to develop produc

Sales & Marketing

Changing Faces: Agency, consultancy, and investor hires, Aug...

August and September brought leadership changes across healthcare communications, consulting, investment, and industry organisations.

Sales & Marketing

Why Klick Health, Oxford PharmaGenesis chose to join forces

Leadership from Klick Health and Oxford PharmaGenesis discuss their

Digital

pharmaphorum podcast Episode 280, Robbie Tyrie, Torridon Cyber

AI governance & cybersecurity: Torridon Cyber’s Robbie Tyrie

Robbie Tyrie, founder and managing director of Torridon Cyber, talks cybersecurity when it comes to AI, pharma companies, and health systems.

Digital

Pharma’s next security problem isn’t the code. It’s what the...

As AI becomes embedded throughout development, innovation must be matched by equally sophisticated approaches to software security.

Market Access

Two pills in the middle of multiple £1 coins

UK’s next pricing and access scheme to last for 7 years

Operational review meeting minutes released by the DHSC reveal industry and government are planning to move to a 7-year agreement.

Market Access

Magnifying glass over pills scattered over dollar and euro notes

One year after MFN: How US policy is reshaping the global ph...

Just over a year has passed since the Trump administration sent letters to 17 leading manufacturers demanding steps towards MFN pricing.

Oncology

Dr Michael Bauer on Quantro’s mission to drug the “undruggab...

Jonah Comstock reunited with Dr Michael Bauer, CEO of Quantro Therapeutics, at LSX 2026 to discuss the company's progress.

Oncology

In vivo CAR-T can solve the delivery problem – but solid tum...

A new generation of in vivo CAR-T cell technologies promises to remove some of the biggest practical barriers to conventional cell therapy.

Oncology

Unlocking the scalability of allogeneic CAR-T

Allogeneic CAR-T, built from healthy donor T-cells, offers a different path toward scale, accessibility, and consistency.

Patients

From bedside to breakthroughs: Reimagining the human experie...

Patients should be involved in the programme design process from the beginning, as co-creators with full influence over the outcome.

Patients

Breaking Bipolar I disorder stigma in the Hispanic community

For many Hispanic patients and families, that is where the gap between need and treatment can begin.

Patients

Durability and earlier access could reshape diabetic retinop...

This year’s World Sight Day turns global attention to the scale of preventable vision loss

Sales & Marketing

Digital

Market Access

Editor's Picks

Oncology

Patients

R&D

Editor's Picks